C-MET / HGF Inhibitors Global Market 2019 Top Key Players – Abxign,  Abbott Laboratories,  Amgen,  ArQule,  Astex Therapeutics and Forecast to 2025

Global C-MET / HGF Inhibitors Market

WiseGuyRerports.com Presents Global C-MET / HGF Inhibitors Market Insights, Forecast to 2025” New Document to its Studies Database. The Report Contain 148 Pages With Detailed Analysis.

Description

c-Met is a proto-oncogene responsible for encoding the high-affinity receptor for hepatocyte growth factor (HGF). Hepatocyte growth factor is also known as scatter factor which participates in HGF/c-MET signaling pathway. This pathway plays vital role in mitogenesis and morphogenesis during embryonic development and wound healing. The controlled natural activity of c-Met and HGF is important in mammalian development, tissue maintenance, and repair. Binding of HGF to c-MET receptor induces several biological responses collectively known as invasive growth program. These responses are elicited due to activation of several pathways such as RAS pathway, PI3K pathway, STAT pathway, beta-catenin pathway and Notch pathway. However, dysregulation of the HGF/c-MET signaling pathway has been associated with the progression of cancers through activation of oncogenic pathways, angiogenesis and metastasis. 

The major cancers such as breast, colon and non-small-cell lung carcinoma (NSCLC) are being examined for efficacy with c-MET / HGF inhibitors. Several small molecule c-Met kinase inhibitors have demonstrated clinical efficacy in cancer treatment and many clinical trials are underway. However, as the small molecule inhibitors lack specificity or selectivity they can cause toxicity. Therefore, researchers are increasing focus to develop antibody therapeutics against c-Met or HGF. 

 

Get sample Report @ https://www.wiseguyreports.com/sample-request/3377970-global-c-met-hgf-inhibitors-market-insights-forecast-to-2025

The global C-MET / HGF Inhibitors market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the C-MET / HGF Inhibitors market based on company, product type, end user and key regions.

This report studies the global market size of C-MET / HGF Inhibitors in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of C-MET / HGF Inhibitors in these regions. 

This research report categorizes the global C-MET / HGF Inhibitors market by top players/brands, region, type and end user. This report also studies the global C-MET / HGF Inhibitors market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company: 
Abxign 
Abbott Laboratories 
Amgen 
ArQule 
Astex Therapeutics 
AVEO Pharmaceuticals 
Bristol-Myers Squibb(BMS) 
Chroma Therapeutics 
Daiichi Sankyo 
Deciphera Pharmaceuticals 
Eisai 
Eli Lilly 
Exelixis 
Genmab 
Galaxy Biotech 
GlaxoSmithKline(GSK) 
Hutchison MediPharma 
Johnson & Johnson 
Kringle Pharmaceuticals 
Merck 
Methylgene 
Novartis 
Pfizer 
ProMetic BioTherapeutics 
Takeda Pharmaceutical

Market size by Product 
C-Met Biologic Inhibitors 
Small Molecule C-Met Inhibitors 
HGF Antagonist Antibodies 
C-Met Antagonist Antibodies(MetMAb) 
HGF Kringle Variant Antagonists 
Market size by End User 
Hospital Pharmacies 
Retail Pharmacies 
Drug Stores 
Online Sales

Market size by Region 
North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 
Japan 
South Korea 
Australia 
Indonesia 
Singapore 
Malaysia 
Philippines 
Thailand 
Vietnam 
Europe 
Germany 
France 
UK 
Italy 
Spain 
Russia 
Central & South America 
Brazil 
Rest of Central & South America 
Middle East & Africa 
GCC Countries 
Turkey 
Egypt 
South Africa

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3377970-global-c-met-hgf-inhibitors-market-insights-forecast-to-2025

 

Table of Contents -Major Key Points

1 Study Coverage 
1.1 C-MET / HGF Inhibitors Product 
1.2 Market Segments 
1.3 Key Manufacturers Covered 
1.4 Market by Type 
1.4.1 Global C-MET / HGF Inhibitors Market Size Growth Rate by Product 
1.4.2 C-Met Biologic Inhibitors 
1.4.3 Small Molecule C-Met Inhibitors 
1.4.4 HGF Antagonist Antibodies 
1.4.5 C-Met Antagonist Antibodies(MetMAb) 
1.4.6 HGF Kringle Variant Antagonists 
1.5 Market by End User 
1.5.1 Global C-MET / HGF Inhibitors Market Size Growth Rate by End User 
1.5.2 Hospital Pharmacies 
1.5.3 Retail Pharmacies 
1.5.4 Drug Stores 
1.5.5 Online Sales 
1.6 Study Objectives 
1.7 Years Considered

2 Executive Summary 
2.1 Global C-MET / HGF Inhibitors Market Size 
2.1.1 Global C-MET / HGF Inhibitors Revenue 2014-2025 
2.1.2 Global C-MET / HGF Inhibitors Sales 2014-2025 
2.2 C-MET / HGF Inhibitors Growth Rate by Regions 
2.2.1 Global C-MET / HGF Inhibitors Sales by Regions 
2.2.2 Global C-MET / HGF Inhibitors Revenue by Regions

…………

11 Company Profiles 
11.1 Abxign 
11.1.1 Abxign Company Details 
11.1.2 Company Business Overview 
11.1.3 Abxign C-MET / HGF Inhibitors Sales, Revenue and Gross Margin (2014-2019) 
11.1.4 Abxign C-MET / HGF Inhibitors Products Offered 
11.1.5 Abxign Recent Development 
11.2 Abbott Laboratories 
11.2.1 Abbott Laboratories Company Details 
11.2.2 Company Business Overview 
11.2.3 Abbott Laboratories C-MET / HGF Inhibitors Sales, Revenue and Gross Margin (2014-2019) 
11.2.4 Abbott Laboratories C-MET / HGF Inhibitors Products Offered 
11.2.5 Abbott Laboratories Recent Development 
11.3 Amgen 
11.3.1 Amgen Company Details 
11.3.2 Company Business Overview 
11.3.Amgen C-MET / HGF Inhibitors Sales, Revenue and Gross Margin (2014-2019) 
11.3.4 Amgen C-MET / HGF Inhibitors Products Offered 
11.3.5 Amgen Recent Development 
11.4 ArQule 
11.4.1 ArQule Company Details 
11.4.2 Company Business Overview 
11.4.3 ArQule C-MET / HGF Inhibitors Sales, Revenue and Gross Margin (2014-2019) 
11.4.4 ArQule C-MET / HGF Inhibitors Products Offered 
11.4.5 ArQule Recent Development 
11.5 Astex Therapeutics 
11.5.1 Astex Therapeutics Company Details 
11.5.2 Company Business Overview 
11.5.3 Astex Therapeutics C-MET / HGF Inhibitors Sales, Revenue and Gross Margin (2014-2019) 
11.5.4 Astex Therapeutics C-MET / HGF Inhibitors Products Offered 
11.5.5 Astex Therapeutics Recent Development 
11.6 AVEO Pharmaceuticals 
11.6.1 AVEO Pharmaceuticals Company Details 
11.6.2 Company Business Overview 
11.6.3 AVEO Pharmaceuticals C-MET / HGF Inhibitors Sales, Revenue and Gross Margin (2014-2019) 
11.6.4 AVEO Pharmaceuticals C-MET / HGF Inhibitors Products Offered 
11.6.5 AVEO Pharmaceuticals Recent Development 

……..CONTINUED

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Industry research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)         

This release was published on openPR.